
Capricor Therapeutics, Inc.
CAPRNasdaqCIK 1133869HealthcareFiscal year ends Dec 31
Reports and events: 339 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-02-2916:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-002183 |
| 2024-01-1109:00 ET | 8-K | 8.01 Other events | 0001558370-24-000197 |
| 2023-12-1116:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-23-019717 |
| 2023-11-1417:16 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001558370-23-019065 |
| 2023-11-1416:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-23-019019 |
| 2023-09-2917:00 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-23-016171 |
| 2023-09-2907:30 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-23-016149 |
| 2023-09-0609:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001558370-23-015482 |
| 2023-08-0808:01 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001558370-23-013763 |
| 2023-08-0716:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-23-013590 |
| 2023-07-2408:35 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001558370-23-012106 |
| 2023-07-1308:31 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001558370-23-011854 |
| 2023-06-1517:26 ET | 8-K/A | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001558370-23-011153 |
| 2023-06-1517:25 ET | 8-K/A | 5.07 Shareholder vote results | 0001558370-23-011151 |
| 2023-06-1317:20 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001558370-23-011050 |
| 2023-06-1317:15 ET | 8-K | 5.07 Shareholder vote results | 0001558370-23-011046 |
| 2023-05-1209:00 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001558370-23-009521 |
| 2023-05-1116:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-23-009363 |
| 2023-04-1717:01 ET | DEF 14A | Proxy statement | 0001558370-23-006082 |
| 2023-03-1717:00 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001558370-23-004124 |
| 2023-03-1516:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-23-003866 |
| 2023-02-1616:15 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001558370-23-001454 |
| 2022-11-1017:16 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001558370-22-017470 |
| 2022-11-1016:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-22-017398 |
| 2022-08-1220:02 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001558370-22-013383 |
| 2022-08-1016:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-22-013054 |
| 2022-07-1912:37 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-22-010821 |
| 2022-06-2917:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-22-010449 |
| 2022-06-0717:09 ET | 8-K | 5.07 Shareholder vote results | 0001558370-22-009778 |
| 2022-05-1117:04 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001558370-22-008347 |
| 2022-05-1016:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-22-008086 |
| 2022-04-1217:00 ET | DEF 14A | Proxy statementPeriod 2022-06-03 | 0001558370-22-005327 |
| 2022-04-0108:30 ET | 8-K | 8.01 Other events | 0001558370-22-005003 |
| 2022-03-1120:00 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001558370-22-003341 |
| 2022-03-1016:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-22-003276 |
| 2022-01-2506:01 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001558370-22-000403 |
| 2021-11-1219:00 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001558370-21-015571 |
| 2021-11-0916:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-21-015262 |
| 2021-09-2411:31 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-21-119139 |
| 2021-08-1309:16 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001558370-21-011587 |
| 2021-08-1216:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-21-011461 |
| 2021-07-2708:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001558370-21-009299 |
| 2021-06-2108:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-21-083149 |
| 2021-06-1719:00 ET | 8-K | 5.07 Shareholder vote results | 0001104659-21-082129 |
| 2021-05-1417:16 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001558370-21-007293 |
| 2021-05-1316:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-21-065924 |
| 2021-04-3008:01 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-21-058250 |
| 2021-04-2016:30 ET | DEF 14A | Proxy statementPeriod 2021-06-11 | 0001104659-21-052552 |
| 2021-03-1517:27 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001104659-21-036410 |
| 2021-03-1116:01 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-21-034985 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 18:39 ET. Listed shows no prices and gives no investment advice.